Prenatal Disorder
12
1
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Ensuring Patients' Informed Access to Noninvasive Prenatal Testing
Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes
Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education
Personalized Integrated Chronotherapy for Perinatal Depression
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
Fetal Ano-genital Distance in 2D Ultrasound.
Develop a Multi-disciplinary Approach for a Personalized Prenatal Diagnostics and Care for Twin Pregnancies
Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits
CGH Array in Bilateral Clubfoot
CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction
Frequency and Type of Genetic Abnormalities Found in Antenatal Corpus Callosum Malformation
Game-Based Decision Aid to Educate Pregnant Women About Prenatal Screening